A Placebo-controlled, Single-blind, Cross-over, Randomised, fMRI Study Comparing Cue-induced Brain Activation Patterns After a Single Oral Dose of GSK598809 or Placebo in Abstinent Alcoholic Subjects
Latest Information Update: 25 Aug 2023
Price :
$35 *
At a glance
- Drugs GSK 598809 (Primary)
- Indications Alcohol withdrawal
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 16 Apr 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 15 May 2014 New trial record